Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 13, 2008

View Archived Issues

Labopharm reports positive results for phase III trazodone study

e-STAR data show risperidone long-acting injection beneficial in schizophrenia

Add-on pimavanserin improves efficacy and safety of risperidone in schizophrenia

Cervical cancer vaccine safe, immunogenic in stage IB and IIA patients

Pro-Pharmaceuticals reports encouraging data from phase II trial of Davanat in colorectal cancer

Blood pressure control safely achieved with clevidipine in high risk patients

AstraZeneca submits application for Seroquel and Seroquel XR in the E.U.

Keryx Biopharmaceuticals completes phase III clinical trial of Sulonex

La Jolla Pharmaceutical presents an update on the phase III trial of Riquent for SLE

Recent patents impart novel treatment options for cancer

Washington University investigators study role of moss protein in Alzheimer's disease

Targanta submits NDA to FDA for oritavancin

Preliminary clinical data show significant HIV viral load reduction with IDX-899

Silodosin NDA accepted for filing by FDA for benign prostatic hyperplasia

Biovitrum completes exploratory phase II study of BVT-28949 in glaucoma

Positive efficacy data reported from phase II Gabapentin GR trial

SCH-532706 safe and well tolerated in combination with ritonavir

Valeant reports positive phase III results for retigabine in RESTORE 1

Decapeptyl 6-month formulation shows similar efficacy to 3-month triptorelin

Study shows self-applied diarrhea vaccine patch has robust immune response

Recent Merck patents describe novel agents for sleep disorders

Recent Allergan patents disclose new therapeutics for glaucoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...